Essenlix Corporation
Monmouth Junction, New Jersey, United States
Purpose
To develop a fast, cost-effective point of care CD4 cell count assay from capillary blood for LMICs.
Division
Global Health
Date
November 2024
Region Served
GLOBAL
Committed amount
$310,675
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
17
Grantee location
Monmouth Junction, New Jersey, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.